HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Fabricant Will Helm FDA Dietary Supplement Office

This article was originally published in The Tan Sheet

Executive Summary

Daniel Fabricant, who championed the dietary supplement industry for the past five years as a Natural Products Association executive, now will oversee supplement industry regulation as an FDA official.

You may also be interested in...



Trade Groups Dismiss Jarrow’s Criticism Of FDA’s Fabricant

Dietary supplement industry trade groups disavow statements by Jarrow Formulas’ president that cast as industry consensus his criticism of Daniel Fabricant’s work as FDA’s top supplement program official.

Interview: CRN Vet Shao Brings Broad Industry Perspective To Herbalife

The dietary supplement industry lost one of its most active and vocal scientific leaders in Washington when Andrew Shao departed the Council for Responsible Nutrition for an executive post with Herbalife.

People In Brief

Mann leaves Pfizer for Bayer Consumer

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS134428

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel